CONCUSSION DRUG STUDY SHOWS POSITIVE EARLY RESULTS
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Michael Rippee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 clinical trial for OXE103 for the treatment of concussion is being conducted at University of Kansas Medical Center, Kansas City, KansasEnrolling...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.